![Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13051765:255v56n09-13051765tab07.gif?idApp=UINPBA000025)
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología
![Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717368183-fx1.jpg)
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? - ScienceDirect
![Abstract 4536: Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Non-Cardiovascular Surgery; a Randomized Controlled Trial | Circulation Abstract 4536: Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Non-Cardiovascular Surgery; a Randomized Controlled Trial | Circulation](https://www.ahajournals.org/cms/asset/79558baa-c7b2-4faa-86e8-1fe8c47b3e8d/4536f1.jpg)
Abstract 4536: Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Non-Cardiovascular Surgery; a Randomized Controlled Trial | Circulation
![PDF] Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? | Semantic Scholar PDF] Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/59f68f2e3f997edd14f99d5540886f0e310fa215/3-Table1-1.png)
PDF] Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement? | Semantic Scholar
![Starting and target doses for commonly used neurohormonal antagonists... | Download Scientific Diagram Starting and target doses for commonly used neurohormonal antagonists... | Download Scientific Diagram](https://www.researchgate.net/publication/324250921/figure/tbl1/AS:745293431726081@1554703209680/Starting-and-target-doses-for-commonly-used-neurohormonal-antagonists-used-in-patients.png)
Starting and target doses for commonly used neurohormonal antagonists... | Download Scientific Diagram
![Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13051765:255v56n09-13051765tab01.gif?idApp=UINPBA000025)
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología
![Potential Starting Doses and Titration of Comprehensive Disease-modifying Medical Therapy | Radcliffe Cardiology Potential Starting Doses and Titration of Comprehensive Disease-modifying Medical Therapy | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2021-11/table3-potential-starting-doses.png?VersionId=pfMapIKT2ltQoUcu1Ba0Dl2ALjbVgJJ7)
Potential Starting Doses and Titration of Comprehensive Disease-modifying Medical Therapy | Radcliffe Cardiology
![Beta-blockers for heart failure: an evidence based review answering practical therapeutic questions. | Semantic Scholar Beta-blockers for heart failure: an evidence based review answering practical therapeutic questions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4f0fea7a8523e70b4a8df1dd5a9a88328c416ad0/3-TableII-1.png)